N.H. Admin. Code § Med 502.04

Current through Register No. 50, December 12, 2024
Section Med 502.04 - Acute Pain

If opioids are indicated and clinically appropriate for prescription for acute pain, prescribing licensees shall:

(a) Conduct and document a physical examination and history;
(b) Consider the patient's risk for opioid misuse, abuse, or diversion and prescribe for the lowest effective dose for a limited duration;
(c) Document the prescription and rationale for all opioids according to Med 501.02(d) and (e);
(d) Ensure that the patient has been provided information that contains the following:
(1) Risk of side effects, including addiction and overdose resulting in death;
(2) Risks of keeping unused medication;
(3) Options for safely securing and disposing of unused medication; and
(4) Danger in operating motor vehicle or heavy machinery;
(e) Comply with all federal and state controlled substances laws, rules, and regulations;
(f) Complete a board-approved risk assessment tool, such as the evidence based screening tool Screener and Opioid Assessment for Patients with Pain (SOAPP);
(g) Document an appropriate pain treatment plan and consideration of non-pharmacological modalities and non-opioid therapy;
(h) Utilize a written informed consent that explains the following risks associated with opioids:
(1) Addiction;
(2) Overdose and death;
(3) Physical dependence;
(4) Physical side effects;
(5) Hyperalgesia;
(6) Tolerance; and
(7) Crime victimization;
(i) In an emergency department, urgent care setting, or walk-in clinic:
(1) Not prescribe more than the minimum amount of opioids medically necessary to treat the patient's medical condition. In most cases, an opioid prescription of 3 or fewer days is sufficient, but a licensee shall not prescribe for more than 7 days; and
(2) If prescribing an opioid for acute pain that exceeds a board-approved limit, document the medical condition and appropriate clinical rationale in the patient's medical record.
(j) Prescribers shall not be obligated to prescribe opioids for more than 30 days, but if opioids are indicated and appropriate for persistent, unresolved acute pain that extends beyond a period of 30 days, the licensee shall conduct an in-office follow-up with the patient prior to issuing a new opioid prescription.

N.H. Admin. Code § Med 502.04

Derived From Volume XXXVI Number 49, Filed December 8, 2016, Proposed by #12038, Effective 1/1/2017, Expires 1/1/2027.